https://www.clinicaltrialsarena.com/news/newssunovion-reports-topline-results-from-phase-iiiii-sep360-221-study-of-dasotraline-to-treat-bed-5716511/
Sunovion reports results from Phase II/III (SEP360-221) study of dasotraline to treat BED -...
Jan 15, 2017 - US-based biopharmaceutical company Sunovion has reported results from its Phase II/III (SEP360-221) study of dasotraline to treat moderate-to-severe binge...
results fromphase iisunovionreportsiii
https://www.business-standard.com/article/companies/lupin-inks-pact-to-acquire-two-inhalation-brands-from-sunovion-for-75-mn-122102000269_1.html
Lupin inks pact to acquire two inhalation brands from Sunovion for $75 mn | Company News - Business...
Drug maker Lupin on Thursday said it will acquire two inhalation brands from Sunovion Pharmaceuticals Inc for USD 75 million (around Rs 622 crore).
company newslupininkspactacquire
https://www.ncbi.nlm.nih.gov/Structure/pdb/4YQH
4YQH: 2-[2-(4-Phenyl-1H-imidazol-2-yl)ethyl]quinoxaline (Sunovion Compound 14) co-crystallized with...
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A2-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]quinoxalineMAGNESIUM IONZINC ION
ylquinoxalinesunovioncompound
https://www.ded.uscourts.gov/opinion/sunovion-pharmaceuticals-inc-v-dey-pharma-lp-et-al
SUNOVION PHARMACEUTICALS INC. v. DEY PHARMA., L.P., et al. | District of Delaware | United States...
district of delawareet alunited statessunovionpharmaceuticals